Removing analytical bottlenecks in cell therapy [WEBINAR]

Numerous cellular therapy candidates are quickly progressing to clinical stage manufacturing. Advances in automated processing have substantially reduced the development efforts needed for GMP-compliant manufacturing strategies. However, many therapeutics are delayed getting into the clinic 
due to lack of suitable analytical methods at an appropriate level of quality.   

Flow cytometry is the predominant modality in cell therapy, employed to determine incoming product 
quality and composition, perform in-process-control (IPC), and ensure cellular identity and purity of final drug products. 

Miltenyi Biotec is a global provider of products and services that empower biomedical discovery and advance cellular therapy Our innovative tools support research at every level, from basic research to translational research to clinical application. This integrated portfolio enables scientists and clinicians to obtain, analyze, and utilize the cell. Our technologies enable solutions for cellular research, cell therapy, cell manufacturing, and imaging.. Our 30 years of expertise spans research areas including immunology, stem cell biology, neuroscience, and cancer, and clinical research areas like hematology, graft engineering, and apheresis. In our commitment to the scientific community, we also offer comprehensive scientific support, consultation, and expert training. Today, Miltenyi Biotec more than 3,000 employees in 28 countries – all dedicated to helping researchers and clinicians around the world make a greater impact on science and health.

Видео Removing analytical bottlenecks in cell therapy [WEBINAR] канала Miltenyi Biotec